Prospective, randomized trial of basiliximab (Simulect) in the prophylaxis of high-risk keratoplasty patients

Trial Profile

Prospective, randomized trial of basiliximab (Simulect) in the prophylaxis of high-risk keratoplasty patients

Completed
Phase of Trial: Phase II

Latest Information Update: 27 Sep 2013

At a glance

  • Drugs Basiliximab (Primary) ; Ciclosporin
  • Indications Keratoplasty rejection
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Dec 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top